Call Us
"Real results start with the right diagnosis."
Our Medical Weight Loss Program doesn't just hand you a prescription. We start by understanding your body through comprehensive blood testing, hormone analysis, and metabolic assessment — then build a personalized plan that actually works with your biology.
Our Approach
- Start with comprehensive blood testing to find the root cause
- Choose the right tool: peptides, GLP-1 medications, or both
- Personalize the program to your hormones, metabolism, and lifestyle
- Monitor, adjust, and support long-term results
This Program Includes
- Step 1: Comprehensive Blood Testing & Body Analysis
- Step 2: Personalized Treatment Plan (Peptides / GLP-1 / Both)
- Step 3: Medical Weight Loss Medication (Mounjaro / Wegovy / Peptides)
- Step 4: Ongoing Monitoring & Lifestyle Support
GLP-1 Weight Loss Medications
Mounjaro (Tirzepatide) & Wegovy (Semaglutide)
What Are GLP-1 Receptor Agonists?
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a class of medications that mimic hormones released by the gut after eating. They regulate appetite, blood sugar, gastric emptying, and insulin response — creating a powerful, evidence-backed environment for sustained weight loss.
These are among the most clinically studied weight loss medications available, with significant results published in major peer-reviewed trials.
Mounjaro (Tirzepatide)
GLP-1 + GIP · Eli Lilly, Weekly Injection — Dual GLP-1 / GIP Agonist
How It Works
Mounjaro activates BOTH the GLP-1 and GIP receptors — a dual-hormone approach that is more effective than single GLP-1 therapy alone. It reduces appetite, slows gastric emptying, improves insulin sensitivity, and significantly reduces visceral fat.
Wegovy (Semaglutide)
GLP-1 · Novo Nordisk, Weekly Injection — GLP-1 Receptor Agonist
How It Works
Wegovy (semaglutide 2.4 mg) is the higher-dose version of Ozempic, specifically approved for chronic weight management. It mimics GLP-1 to reduce appetite, increase satiety, and improve blood sugar regulation — leading to sustained, clinically meaningful weight loss.
Mounjaro vs Wegovy Comparison
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Mechanism | Dual GLP-1 + GIP agonist | Single GLP-1 agonist |
| Active compound | Tirzepatide | Semaglutide 2.4 mg |
| Average weight loss | 15–22% body weight | 12–15% body weight |
| Dosing | 2.5–15 mg weekly | 0.25–2.4 mg weekly |
| Titration period | 4–12 weeks | 16–20 weeks |
| Best for | Maximum weight loss, insulin resistance | Long-term maintenance, CV risk reduction |
| FDA approved for | Type 2 diabetes + weight (US) | Chronic weight management |
| Injection frequency | Once weekly | Once weekly |
Physician consultation, blood work, and medical assessment required before initiating either medication. Prescription and monitoring are mandatory.
Peptide Weight Loss Protocols
Natural metabolic support — peptides for fat loss and body recomposition
Peptides For Weight Loss & Body Recompositing
Peptides offer a targeted, natural approach to fat loss and body recompositing — either standalone for early-stage weight management or combined with GLP-1 medications for enhanced results. Each peptide targets a specific metabolic pathway.
Our Peptide Available
AOD-9604, CJC-1295, Ipamorelin, Tesamorelin, 5-Amino-1MQ, Tesofensine, SLU-PP-332,
Growth hormone peptides (CJC-1295, Ipamorelin, Tesamorelin) require fasting 2–3 hours before injection for maximum GH release.
Peptide protocols are individually tailored based on blood work results and treatment goals. Stacking may be recommended by your physician.
